1,552
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

The treatment efficacy of three-layered functional polymer materials as drug carrier for orthotopic colon cancer

, , &
Pages 2971-2983 | Received 18 Jul 2022, Accepted 04 Sep 2022, Published online: 13 Sep 2022

References

  • Arnold M, Sierra MS, Laversanne M, et al. (2017). Global patterns and trends in colorectal cancer incidence and mortality. Gut 66:683–91.
  • Brede C, Labhasetwar V. (2013). Applications of nanoparticles in the detection and treatment of kidney diseases. Adv Chronic Kidney Dis 20:454–65.
  • Chen K, Pan H, Yan Z, et al. (2021). A novel alginate/gelatin sponge combined with curcumin-loaded electrospun fibers for postoperative rapid hemostasis and prevention of tumor recurrence. Int J Biol Macromol 182:1339–50.
  • Cornelissen LAM, Blanas A, Van Der Horst JC, et al. (2019). Disruption of sialic acid metabolism drives tumor growth by augmenting CD8(+) T cell apoptosis. Int J Cancer 144:2290–302.
  • Feng X, Li J, Zhang X, et al. (2019). Electrospun polymer micro/nanofibers as pharmaceutical repositories for healthcare. J Control Release 302:19–41.
  • Gagliardi A, Giuliano E, Venkateswararao E, et al. (2021). Biodegradable polymeric nanoparticles for drug delivery to solid tumors. Front Pharmacol 12:601626.
  • Ge H, Du J, Long S, et al. (2021). Surface functionalized gold nanomaterials in tumor diagnosis and treatment. Chem J Chinese Universities-Chinese 42:1202–12.
  • Ghafoor B, Aleem A, Ali MN, Mir M. (2018). Review of the fabrication techniques and applications of polymeric electrospun nanofibers for drug delivery systems. J Drug Deliv Sci Technol 48:82–7.
  • Jacob S, Nair AB, Shah J, et al. (2021). Emerging role of hydrogels in drug delivery systems, tissue engineering and wound management. Pharmaceutics 13:357.
  • Jeong JY, Hong E-H, Lee SY, et al. (2017). Boronic acid-tethered amphiphilic hyaluronic acid derivative-based nanoassemblies for tumor targeting and penetration. Acta Biomater 53:414–26.
  • Ji M, Li P, Sheng N, et al. (2016). Sialic acid-targeted nanovectors with phenylboronic acid-grafted polyethylenimine robustly enhance siRNA-based cancer therapy. ACS Appl Mater Interfaces 8:9565–76.
  • Jin C, Wang K, Oppong-Gyebi A, Hu J. (2020). Application of nanotechnology in cancer diagnosis and therapy - a mini-review. Int J Med Sci 17:2964–73.
  • Kanemitsu Y, Shitara K, Mizusawa J, JCOG Colorectal Cancer Study Group, et al. (2021). Primary tumor resection plus chemotherapy versus chemotherapy alone for colorectal cancer patients with asymptomatic, synchronous unresectable metastases (JCOG1007; iPACS): a randomized clinical trial. J Clin Oncol 39:1098–+.
  • Luraghi A, Peri F, Moroni L. (2021). Electrospinning for drug delivery applications: a review. J Control Release 334:463–84.
  • Murono K, Kawai K, Hata K, et al. (2018). Regimens of intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal cancer. Anticancer Res 38:15–22.
  • Nakhjavani M, Smith E, Yeo K, et al. (2021). Anti-angiogenic properties of ginsenoside Rg3 epimers: in vitro assessment of single and combination treatments. Cancers 13:2223.
  • Nalli M, Puxeddu M, La Regina G, et al. (2021). Emerging therapeutic agents for colorectal cancer. Molecules 26:7463.
  • Niotis A, Tsiambas E, Fotiades PP, et al. (2018). ki-67 and Topoisomerase IIa proliferation markers in colon adenocarcinoma. J BUON 23:24–7.
  • Parhi R. (2017). Cross-linked hydrogel for pharmaceutical applications: a review. Adv Pharm Bull 7:515–30.
  • Power DG, Kemeny NE. (2010). Role of adjuvant therapy after resection of colorectal cancer liver metastases. J Clin Oncol 28:2300–9.
  • Quenet F, Elias D, Roca L, UNICANCER-GI Group and BIG Renape Group, et al. (2021). Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol 22:256–66.
  • Redondo PDG, Nakamura CV, de Souza W, Morgado-Díaz JA. (2004). Differential expression of sialic acid and N-acetylgalactosamine residues on the cell surface of intestinal epithelial cells according to normal or metastatic potential. J Histochem Cytochem 52:629–40.
  • Siegel RL, Miller KD, Fuchs HE, Jemal A. (2021). Cancer Statistics, 2021. CA Cancer J Clin 71:7–33.
  • Spindler BA, Bergquist JR, Thiels CA, et al. (2017). Incorporation of CEA improves risk stratification in stage II colon cancer. J Gastrointest Surg 21:770–7.
  • Sung H, Ferlay J, Siegel RL, et al. (2021). Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71:209–49.
  • Yang L-Q, Wang B, Gan H, et al. (2012). Enhanced oral bioavailability and anti-tumour effect of paclitaxel by 20(s)-ginsenoside Rg3 in vivo. Biopharm Drug Dispos 33:425–36.
  • Yang X-L, Huang T-L, Cai H-Y, et al. (2019). Synergistic antitumor effect of 20-(R)-Rg(3) combined with 5-fluorouracil on HCT-116 cell. Int J Clin Exp Med 12:3238–49.
  • Yoshida D, Ikeda Y, Waki K, et al. (2012). Different incidence of synchronous liver metastasis between proximal and distal colon cancer. Surg Today 42:426–30.
  • Zhang K, Xue K, Loh XJ. (2021). Thermo-responsive hydrogels: from recent progress to biomedical applications. Gels 7:77.
  • Zheng X, Chen W, Hou H, et al. (2017). Ginsenoside 20(S)-Rg3 induced autophagy to inhibit migration and invasion of ovarian cancer. Biomed Pharmacother 85:620–6.
  • Zhou X, Zhai Y, Liu C, et al. (2020). Sialidase NEU1 suppresses progression of human bladder cancer cells by inhibiting fibronectin-integrin alpha 5 beta 1 interaction and Akt signaling pathway. Cell Commun Signal 18:44.